This Company Generates No Revenue and Its Market Cap Is Over $20 Billion. Here's Why That Valuation May Not Be All That Ridiculous.
Summit Therapeutics Inc. Common Stock · PHARMACEUTICAL PREPARATIONS · Now $15.71
+13% in 1d after detection
Post-detection moves
1h
—
1d
+13%
3d
+4.9%
7d
+11%
30d
—
Get alerts like this in real time
Push notifications the moment a signal fires. No spam, no crypto, no fluff.
Download for iOS